PAVmed Inc. Gain (Loss) on Extinguishment of Debt
PAVmed Inc. (PAVM) reported Gain (Loss) on Extinguishment of Debt of -$58.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-13
- PAVmed Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$116.00K.
- PAVmed Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $116.00K.
- PAVmed Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- PAVmed Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was -$58.00K.
- PAVmed Inc. gain (loss) on extinguishment of debt for fiscal 2025 was -$58.00K.
- PAVmed Inc. gain (loss) on extinguishment of debt for fiscal 2024 was -$2.54M.
- PAVmed Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $3.71M.
- PAVmed Inc. gain (loss) on extinguishment of debt for fiscal 2019 was $1.83M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | -$58.00K 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $116.00K derived: sum of 2 quarters · filed 2026-08-13 | $58.00K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$58.00K 10-Q · filed 2026-08-13 | $58.00K 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | -$58.00K 10-Q · filed 2026-05-14 | $58.00K 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | -$2.54M 10-K · filed 2026-03-27 | |||||
| 2022-09-30 | -$5.12M 10-Q · filed 2023-11-13 | $5.10M 10-Q · filed 2022-11-14 | -$5.12M 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $7.43M derived: sum of 2 quarters · filed 2023-03-14 | $7.43M derived: sum of 3 quarters · filed 2023-03-14 | $3.71M 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $7.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $7.43M derived: sum of 2 quarters · filed 2022-11-14 | $3.71M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.71M 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | -$3.71M 10-Q · filed 2022-05-16 | |||||
| 2020-03-31 | $1.20M 10-Q · filed 2020-05-28 | $2.36M derived: sum of 2 quarters · filed 2020-05-28 | $2.77M derived: sum of 3 quarters · filed 2020-05-28 | |||
| 2019-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | $1.57M derived: sum of 2 quarters · filed 2020-04-14 | $1.83M 10-K · filed 2020-04-14 | |||
| 2019-09-30 | $406.86K 10-Q · filed 2019-11-19 | $666.67K 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |